A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
Cailin H Sibley, Andrea Chioato, Sandra Felix, Laurence Colin, Abhijit Chakraborty, Nikki Plass, Jackeline Rodriguez-Smith, Carmen Brewer, Kelly King, Christopher Zalewski, H Jeffrey Kim, Rachel Bishop, Ken Abrams, Deborah Stone, Dawn Chapelle, Bahar Kost, Christopher Snyder, John A Butman, Robert Wesley, Raphaela Goldbach-Mansky
Annals of the Rheumatic Diseases Sep 2015, 74 (9) 1714-1719; DOI: 10.1136/annrheumdis-2013-204877